Pharsight

Drugs that contain Latanoprost

1. Xelpros patents expiration

XELPROS Litigations
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9539262 SUN PHARM Ophthalmic composition comprising a prostaglandin
Oct, 2028

(4 years from now)

US9629852 SUN PHARM Ophthalmic composition comprising a prostaglandin
Sep, 2029

(5 years from now)

Market Authorisation Date: 12 September, 2018

Treatment: Reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension

Dosage: EMULSION;OPHTHALMIC

More Information on Dosage

XELPROS family patents

Family Patents